| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,605 |
5,347 |
$427K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,831 |
4,635 |
$293K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,832 |
2,673 |
$261K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,145 |
3,011 |
$220K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
6,534 |
5,849 |
$163K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,804 |
3,490 |
$85K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,532 |
2,995 |
$60K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,062 |
3,786 |
$43K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,328 |
1,277 |
$38K |
| 99051 |
|
1,542 |
1,489 |
$21K |
| 81003 |
|
223 |
216 |
$352.34 |
| 71046 |
Radiologic examination, chest; 2 views |
27 |
15 |
$336.11 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
55 |
53 |
$102.62 |
| 81025 |
|
18 |
17 |
$98.67 |
| 99000 |
|
2,810 |
2,568 |
$33.30 |